The EESC has been requested by the Commission to prepare an Opinion which will contribute to shaping the EU position on the post 2015 HFA to be presented during the UN-led negotiations in July and November this year. The Committee's Opinion will be important given that the Commission Communication proposes involvement of civil society and private sector in decision making and implementation of actions related to disaster risk management within the post 2015 HFA.
Download — The post 2015 Hyogo Framework for Action: Managing risks to achieve resilience
The EESC stresses that a real growth strategy at EU and national level is needed to support the creation of better and more stable jobs for young people.
Download — Employability of young people – matching training with industry needs in an age of austerity
The EESC welcomes the Communication as a significant and helpful support for the implementation of the Core Network Corridors and the predefined projects in them. The EESC appreciates the Communications’ focus on the governance system and the support it provides for the development of the work plans for the Core Network Corridors.
The European Commission under the European Strategy 2020 has established a goal to raise the industry contribution to GDP from 15.6% (2011) to 20% by 2020. The Industrial Policy Communication updated of October 2012 outlines a strategy to reverse the declining role of industry announcing actions in four main areas: Investment in new technologies and innovation; Access to Markets; Access to Finance and Human capital and skills.
Download — Reshoring of EU industries in the framework of reindustrialisation
Due to the increased need for cost-efficient procedures and the pressure on public expenditure, the European market for pharmaceutical products is less dynamic than in the past. This high-technology sector is faced with the following challenges: austerity measures introduced by European governments, rapid growth in the market and research in emerging economies, and migration of economic, research and development activities outside of Europe.
Download — Industrial Changes in the European Pharmaceutical Sector
